 |
|
Inhibition of plasminogen activator inhibitor-1 attenuates against intestinal fibrosis in mice
Jin Imai, Takashi Yahata, Hitoshi Ichikawa, Abd Aziz Ibrahim, Masaki Yazawa, Hideaki Sumiyoshi, Yutaka Inagaki, Masashi Matsushima, Takayoshi Suzuki, Tetsuya Mine, Kiyoshi Ando, Toshio Miyata, Katsuto Hozumi
Intest Res. 2020;18(2):219-228. Published online 2020 Feb 17 DOI: https://doi.org/10.5217/ir.2019.00037
|
|
Citations to this article as recorded by
 The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms
Yuling Wang, Linke Jiao, Caoxia Qiang, Chen Chen, Zihuan Shen, Fan Ding, Lifei Lv, Tingting Zhu, Yingdong Lu, Xiangning Cui
Biomedicine & Pharmacotherapy.2024; 171: 116116. CrossRef Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next?
Virginia Solitano, Arianna Dal Buono, Roberto Gabbiadini, Marek Wozny, Alessandro Repici, Antonino Spinelli, Stefania Vetrano, Alessandro Armuzzi
Journal of Clinical Medicine.2023; 12(9): 3052. CrossRef Downregulation of Heat Shock Protein 72 Contributes to Fibrostenosis in Crohn’s Disease
Seung Won Kim, Jae-Young Lee, Han Cheol Lee, Jae Bum Ahn, Ji Hyung Kim, I Seul Park, Jae Hee Cheon, Duk Hwan Kim
Gut and Liver.2023; 17(6): 905. CrossRef Revisiting fibrosis in inflammatory bowel disease: the gut thickens
Silvia D’Alessio, Federica Ungaro, Daniele Noviello, Sara Lovisa, Laurent Peyrin-Biroulet, Silvio Danese
Nature Reviews Gastroenterology & Hepatology.2022; 19(3): 169. CrossRef The Molecular Mechanisms of Intestinal Inflammation and Fibrosis in Crohn’s Disease
Yuki Hayashi, Hiroshi Nakase
Frontiers in Physiology.2022;[Epub] CrossRef Attenuation of Excess TNF-α Release in Crohn’s Disease by Silencing of iRHOMs 1/2 and the Restoration of TGF-β Mediated Immunosuppression Through Modulation of TACE Trafficking
Taylor J. Louis, Ahmad Qasem, Saleh A. Naser
Frontiers in Immunology.2022;[Epub] CrossRef ZNF281 Promotes Colon Fibroblast Activation in TGFβ1-Induced Gut Fibrosis
Ilaria Laudadio, Alex Bastianelli, Valerio Fulci, Claudia Carissimi, Eleonora Colantoni, Francesca Palone, Roberta Vitali, Elisa Lorefice, Salvatore Cucchiara, Anna Negroni, Laura Stronati
International Journal of Molecular Sciences.2022; 23(18): 10261. CrossRef Macrophages in intestinal fibrosis and regression
Hui Yao, Guoyao Tang
Cellular Immunology.2022; 381: 104614. CrossRef Prevention and Treatment of Stricturing Crohn’s Disease – Perspectives and Challenges
Joseph Sleiman, Sara El Ouali, Taha Qazi, Benjamin Cohen, Scott R. Steele, Mark E. Baker, Florian Rieder
Expert Review of Gastroenterology & Hepatology.2021; 15(4): 401. CrossRef Elevated expression of plasminogen activator inhibitor (PAI-1/SERPINE1) is independent from rs1799889 genotypes in arthrofibrosis
Banu Bayram, Aaron R. Owen, Amel Dudakovic, Jacob W. Bettencourt, Afton K. Limberg, Mark E. Morrey, Joaquin Sanchez-Sotelo, Daniel J. Berry, Jean-Pierre A. Kocher, Andre J. van Wijnen, Matthew P. Abdel
Meta Gene.2021; 28: 100877. CrossRef Molecular targets and the use of biologics in the management of small bowel fibrosis in inflammatory bowel disease
Muaad Abdulla, Thean Soon Chew
Current Opinion in Gastroenterology.2021; 37(3): 275. CrossRef Intestinal stricture in Crohn's disease: A 2020 update
Xiao Xuan Lin, Yun Qiu, Xiao Jun Zhuang, Fen Liu, Xiao Min Wu, Min Hu Chen, Ren Mao
Journal of Digestive Diseases.2021; 22(7): 390. CrossRef Therapeutic applications of PAI-1 inhibitor for the treatment of hematological malignancies
Takashi Yahata
Japanese Journal of Thrombosis and Hemostasis.2020; 31(3): 310. CrossRef
|